Top Markets
#1 MowCat MowCat +776.52%
#2 龙虾 (Lobster) 龙虾 (Lobster) +81.61%
#3 Akedo Akedo +49.11%
#4 Magma Finance Magma Finance +41.92%
#5 DeXe DeXe +31.41%
#6 SIXSEVEN SIXSEVEN +29.75%
#7 Cortex Cortex +26.19%
#8 MarsCoin MarsCoin +25.84%
#9 Zignaly Zignaly +17.71%
#10 Staked ZIG Staked ZIG +17.54%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
株式のランク #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
株価
$3.11
時価総額
$1.41B
変化（1日）
-1.97%
変化（1年）
-57.22%
国
CN
取引 Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

カテゴリー

Healthcare
Staidson (Beijing) BioPharmaceuticals Co., Ltd.（300204）の収益
Aug 2026 時点の収益 TTM: 0
Staidson (Beijing) BioPharmaceuticals Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Staidson (Beijing) BioPharmaceuticals Co., Ltd. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH